We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.33%
2 Healthcare 8.9%
3 Financials 7.71%
4 Consumer Discretionary 6.92%
5 Industrials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RP
701
DELISTED
RealPage, Inc.
RP
$13.5M 0.02%
233,808
+61,877
+36% +$3.82M
BSCO
702
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$13.5M 0.02%
606,815
+30,650
+5% +$682K
EXPO icon
703
Exponent
EXPO
$3.18B
$13.4M 0.02%
186,680
+33,509
+22% +$2.66M
IT icon
704
Gartner
IT
$11.5B
$13.4M 0.02%
107,067
+16,929
+19% +$2.15M
XMLV icon
705
Invesco S&P MidCap Low Volatility ETF
XMLV
$743M
$13.4M 0.02%
321,082
-144,493
-31% -$6.15M
LSTR icon
706
Landstar System
LSTR
$6.28B
$13.3M 0.02%
106,383
-11,638
-10% -$1.47M
JNPR
707
DELISTED
Juniper Networks
JNPR
$13.3M 0.02%
620,016
-210,141
-25% -$4.98M
CTAS icon
708
Cintas
CTAS
$82B
$13.3M 0.02%
160,060
-5,064
-3% -$391K
LCII icon
709
LCI Industries
LCII
$2.57B
$13.3M 0.02%
125,285
+8,298
+7% +$966K
LH icon
710
Labcorp
LH
$26.1B
$13.3M 0.02%
82,332
-36,481
-31% -$5.78M
EWG icon
711
iShares MSCI Germany ETF
EWG
$1.67B
$13.3M 0.02%
455,865
+440,584
+2,883% +$12.9M
AMLP icon
712
Alerian MLP ETF
AMLP
$13.2B
$13.3M 0.02%
663,191
+50,502
+8% +$1.17M
EMQQ icon
713
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$271M
$13.2M 0.02%
253,273
+4,481
+2% +$232K
VV icon
714
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
$13.2M 0.02%
84,519
+4,244
+5% +$654K
PCAR icon
715
PACCAR
PCAR
$69.2B
$13.2M 0.02%
232,413
+70,446
+43% +$3.95M
WRB icon
716
W.R. Berkley
WRB
$26B
$13.2M 0.02%
485,498
+152,025
+46% +$4.17M
GMED icon
717
Globus Medical
GMED
$11.3B
$13.1M 0.02%
264,567
+44,538
+20% +$2.3M
HLT icon
718
Hilton Worldwide
HLT
$72.7B
$13.1M 0.02%
153,394
+26,718
+21% +$2.23M
CEF icon
719
Sprott Physical Gold and Silver Trust
CEF
$8.33B
$13.1M 0.02%
712,635
-17,968
-2% -$345K
VYX icon
720
NCR Voyix
VYX
$1.1B
$13M 0.02%
959,553
-26,900
-3% -$320K
VSDA icon
721
VictoryShares Dividend Accelerator ETF
VSDA
$251M
$13M 0.02%
357,923
+74,834
+26% +$2.64M
BMRN icon
722
BioMarin Pharmaceuticals
BMRN
$13.7B
$13M 0.02%
170,490
-26,046
-13% -$2.64M
CGNX icon
723
Cognex
CGNX
$10.4B
$12.9M 0.02%
198,491
+17,136
+9% +$1.11M
DOC
724
DELISTED
PHYSICIANS REALTY TRUST
DOC
$12.9M 0.02%
717,659
-141,415
-16% -$2.52M
EQC
725
DELISTED
Equity Commonwealth
EQC
$12.8M 0.02%
482,533
+207,006
+75% +$6.4M

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.